1. A Benefit-Risk Review of Systemic Haemostatic Agents

   • Ian S. Fraser
   • Robert J Porte
   • Andrea S. Lukes

   Review Article 19 October 2012 Pages: 275 - 282

   

2. Dysglycaemias and Fluoroquinolones

   • Roshan J. Lewis
   • John F. Mohr III

   Review Article 19 October 2012 Pages: 283 - 292

   

3. Propofol Infusion Syndrome

   • Vincenzo Fodale
   • Enza La Monaca

   Review Article 19 October 2012 Pages: 293 - 303

   

4. Adequacy of Patient Information on Adverse Effects

   • Neil Carrigan
   • D. K. Raynor
   • Peter Knapp

   Short Communication 19 October 2012 Pages: 305 - 312

   

5. Safety Profile of Esomeprazole

   • Miranda Davies
   • Lynda V. Wilton
   • Saad A. W. Shakir

   Original Research Article 19 October 2012 Pages: 313 - 323

   

6. Hepatic Effects of Lovastatin Exposure in Patients with Liver Disease

   • Andrew L. Avins
   • Michele M. Manos
   • Jeffrey G. Levine

   Original Research Article 19 October 2012 Pages: 325 - 334

   

7. Improving the Reporting of Adverse Drug Reactions

   • Maria T. Herdeiro
   • Jorge Polónia
   • Adolfo Figueiras

   Original Research Article 19 October 2012 Pages: 335 - 344

   

8. Hepatic Events Associated with Atomoxetine Treatment for Attention-Deficit Hyperactivity Disorder

   • Mark E. Bangs
   • Ling Jin
   • Joachim F. Wernicke

   Original Research Article 19 October 2012 Pages: 345 - 354

   

9. Publishing Histories of Adverse Reactions to Medicaments Anecdotally

   • Jeffrey K. Aronson

   Correspondence 19 October 2012 Pages: 355 - 356

10. The Authors’ Reply

    • William Kelly
    • Nicholas Moore
    • Eugene van Puijenbroek

    Correspondence 19 October 2012 Pages: 356 - 357